289 related articles for article (PubMed ID: 17077202)
1. The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes.
; Crandall J; Schade D; Ma Y; Fujimoto WY; Barrett-Connor E; Fowler S; Dagogo-Jack S; Andres R
J Gerontol A Biol Sci Med Sci; 2006 Oct; 61(10):1075-81. PubMed ID: 17077202
[TBL] [Abstract][Full Text] [Related]
2. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.
; Knowler WC; Fowler SE; Hamman RF; Christophi CA; Hoffman HJ; Brenneman AT; Brown-Friday JO; Goldberg R; Venditti E; Nathan DM
Lancet; 2009 Nov; 374(9702):1677-86. PubMed ID: 19878986
[TBL] [Abstract][Full Text] [Related]
3. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance.
Herman WH; Hoerger TJ; Brandle M; Hicks K; Sorensen S; Zhang P; Hamman RF; Ackermann RT; Engelgau MM; Ratner RE;
Ann Intern Med; 2005 Mar; 142(5):323-32. PubMed ID: 15738451
[TBL] [Abstract][Full Text] [Related]
4. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
Knowler WC; Barrett-Connor E; Fowler SE; Hamman RF; Lachin JM; Walker EA; Nathan DM;
N Engl J Med; 2002 Feb; 346(6):393-403. PubMed ID: 11832527
[TBL] [Abstract][Full Text] [Related]
5. Regression from pre-diabetes to normal glucose regulation in the diabetes prevention program.
Perreault L; Kahn SE; Christophi CA; Knowler WC; Hamman RF;
Diabetes Care; 2009 Sep; 32(9):1583-8. PubMed ID: 19587364
[TBL] [Abstract][Full Text] [Related]
6. Alcohol consumption and diabetes risk in the Diabetes Prevention Program.
Crandall JP; Polsky S; Howard AA; Perreault L; Bray GA; Barrett-Connor E; Brown-Friday J; Whittington T; Foo S; Ma Y; Edelstein SL;
Am J Clin Nutr; 2009 Sep; 90(3):595-601. PubMed ID: 19640960
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study.
Diabetes Prevention Program Research Group
Lancet Diabetes Endocrinol; 2015 Nov; 3(11):866-75. PubMed ID: 26377054
[TBL] [Abstract][Full Text] [Related]
8. Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin.
Kitabchi AE; Temprosa M; Knowler WC; Kahn SE; Fowler SE; Haffner SM; Andres R; Saudek C; Edelstein SL; Arakaki R; Murphy MB; Shamoon H;
Diabetes; 2005 Aug; 54(8):2404-14. PubMed ID: 16046308
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Weight Loss With Metformin or Lifestyle Intervention in the Diabetes Prevention Program Outcomes Study.
Apolzan JW; Venditti EM; Edelstein SL; Knowler WC; Dabelea D; Boyko EJ; Pi-Sunyer X; Kalyani RR; Franks PW; Srikanthan P; Gadde KM;
Ann Intern Med; 2019 May; 170(10):682-690. PubMed ID: 31009939
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes.
Eddy DM; Schlessinger L; Kahn R
Ann Intern Med; 2005 Aug; 143(4):251-64. PubMed ID: 16103469
[TBL] [Abstract][Full Text] [Related]
11. [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations].
Flórez H
Invest Clin; 1997 Mar; 38(1):39-52. PubMed ID: 9235072
[TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome components and their response to lifestyle and metformin interventions are associated with differences in diabetes risk in persons with impaired glucose tolerance.
Florez H; Temprosa MG; Orchard TJ; Mather KJ; Marcovina SM; Barrett-Connor E; Horton E; Saudek C; Pi-Sunyer XF; Ratner RE; Goldberg RB;
Diabetes Obes Metab; 2014 Apr; 16(4):326-33. PubMed ID: 24118860
[TBL] [Abstract][Full Text] [Related]
13. Lifestyle and metformin treatment favorably influence lipoprotein subfraction distribution in the Diabetes Prevention Program.
Goldberg R; Temprosa M; Otvos J; Brunzell J; Marcovina S; Mather K; Arakaki R; Watson K; Horton E; Barrett-Connor E
J Clin Endocrinol Metab; 2013 Oct; 98(10):3989-98. PubMed ID: 23979954
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects of lifestyle and metformin interventions in DPP on bone density.
Schwartz AV; Pan Q; Aroda VR; Crandall JP; Kriska A; Piromalli C; Wallia A; Temprosa M; Florez H;
Osteoporos Int; 2021 Nov; 32(11):2279-2287. PubMed ID: 34086101
[TBL] [Abstract][Full Text] [Related]
15. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial.
Orchard TJ; Temprosa M; Goldberg R; Haffner S; Ratner R; Marcovina S; Fowler S;
Ann Intern Med; 2005 Apr; 142(8):611-9. PubMed ID: 15838067
[TBL] [Abstract][Full Text] [Related]
16. Lifestyle and metformin interventions have a durable effect to lower CRP and tPA levels in the diabetes prevention program except in those who develop diabetes.
Goldberg RB; Temprosa MG; Mather KJ; Orchard TJ; Kitabchi AE; Watson KE;
Diabetes Care; 2014 Aug; 37(8):2253-60. PubMed ID: 24824548
[TBL] [Abstract][Full Text] [Related]
17. Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program.
Knowler WC; Hamman RF; Edelstein SL; Barrett-Connor E; Ehrmann DA; Walker EA; Fowler SE; Nathan DM; Kahn SE;
Diabetes; 2005 Apr; 54(4):1150-6. PubMed ID: 15793255
[TBL] [Abstract][Full Text] [Related]
18. Change in adiponectin explains most of the change in HDL particles induced by lifestyle intervention but not metformin treatment in the Diabetes Prevention Program.
Goldberg RB; Temprosa M; Mele L; Orchard T; Mather K; Bray G; Horton E; Kitabchi A; Krakoff J; Marcovina S; Perreault L; White N;
Metabolism; 2016 May; 65(5):764-775. PubMed ID: 27085783
[TBL] [Abstract][Full Text] [Related]
19. Impact of lifestyle intervention and metformin on health-related quality of life: the diabetes prevention program randomized trial.
Florez H; Pan Q; Ackermann RT; Marrero DG; Barrett-Connor E; Delahanty L; Kriska A; Saudek CD; Goldberg RB; Rubin RR;
J Gen Intern Med; 2012 Dec; 27(12):1594-601. PubMed ID: 22692637
[TBL] [Abstract][Full Text] [Related]
20. The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up.
Aroda VR; Christophi CA; Edelstein SL; Zhang P; Herman WH; Barrett-Connor E; Delahanty LM; Montez MG; Ackermann RT; Zhuo X; Knowler WC; Ratner RE;
J Clin Endocrinol Metab; 2015 Apr; 100(4):1646-53. PubMed ID: 25706240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
